In ovarian cancers, Taniguchi et al. propose a model for ovarian tumor progression in which the initial methylation of FANCF is followed by FANCF demethylation and ultimately results in cisplatin resistance [7]. This evidence concerns the gene FANCF and ovarian carcinoma.